投稿日：2018/04/27(金) 06:30
投稿者：Arthur　[home]　[mail]

I don't know what I want to do after university motilium tablets what are they for Neurocrine Biosciences Inc. (NBIX) said the 50-milligram dose of its treatment for tardive dyskinesia failed to meet its primary endpoint in a Phase IIb study, though the 100-milligram dose showed a statistically significant improvement.